Relationship between plasma concentration and antihypertensive effect of the dihydropyridine calcium antagonist, benidipine, in rats

Journal of Pharmacy and Pharmacology

Volumn 49, Issue 12, 1997, Pages 1200-1204

  Kobayashi, Hiroyuki ^a   Kobayashi, Satoshi ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BENIDIPINE; CALCIUM ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE REGULATION; CELL MEMBRANE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG ELIMINATION; DRUG HALF LIFE; HYSTERESIS; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN RESIDENCE TIME; MESENTERIC ARTERY; NONHUMAN; ORAL DRUG ADMINISTRATION; PHYSICAL CHEMISTRY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0031464736     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1997.tb06070.x     Document Type: Article

References (22)

1. Affolter, H., Coronado, R. (1986) Sidedness of reconstituted calcium channels from muscle transverse tubules as determined by D600 and D900 blockade. Biophys. J. 49: 767-771
2. Chester, D. W., Herbette, L. G., Mason, R. P., Joslyn, A. F., Triggle, D. J., Koppel, D. E. (1987) Diffusion of dihydropyridine calcium channel antagonists in cardiac sarcolemmal lipid multibilayers. Biophys. J. 52: 1021-1030
3. Gotoh, Y., Kumadani, S., Kawai, T., Imaizumi, Y., Watanabe, M. (1989) Slow onset of and recovery from Ca blocking action of benidipine in rat aorta and portal vein. Jpn J. Pharmacol. 51: 37-45
4. Herbette, L. G., Vant Erve, Y. M., Rhodes, D. G. (1989) Interaction of 1,4-dihydropyridine calcium channel antagonists with biological membranes. Lipid bilayer partitioning could occur before drug binding to receptors. J. Mol. Cell. Cardiol. 21: 187-201
5. Herberte, L. G., Rhodes, D. G., Mason, R. P. (1991) New approaches to drug design and delivery based on drug-membrane interactions. Drug Des. Del. 7: 75-118
6. Ishii, A., Nishida, K., Oka, T., Nakamizo, N. (1988a) Receptor binding properties of the new calcium antagonist benidipine hydrochloride. Arzneim. Forsch. 38: 1677-1680
7. Ishii, A., Nishida, K., Oka, T., Nakamizo, N. (1988b) Sensitive radio-receptor assay of the calcium antagonist benidipine hydrochloride in plasma and urine. Arzneim. Forsch. 38: 1733-1737
8. Karasawa, A., Kubo, K., Shuto, K., Oka, T., Nakamizo. N. (1988a) Anti-hypertensive effects of the new calcium antagonist benidipine hydrochloride in rats. Arzneim. Forsch. 38: 1684-1690
9. Karasawa, A., Kubo, K., Oka, T., Nakamizo, N. (1988b) Anti-hypertensive effects of intravenous administration of benidipine hydrochloride and some other calcium antagonists in conscious, spontaneously hypertensive rats. Arzneim. Forsch. 38: 1691-1694
10. Karasawa, A., Ikeda, J., Yamada, K., Kubo, K., Oka, T., Nakamizo, N. (1988c) Anti-hypertensive effects of the new calcium antagonist benidipine hydrochloride in conscious, renal hypertensive dogs. Arzneim. Forsch. 38: 1695-1701
11. Kobayashi, H., Okumura, S., Kosaka, Y., Kobayashi, S., Inoue, A., Oka, T., Nakamizo, N. (1988) Identification of benidipine hydrochloride metabolites in rats and dogs. Arzneim. Forsch. 38: 1753-1756
12. Kobayashi, H., Kobayashi, S., Inoue, A., Hirata, T. (1990) Pharmacokinetic study of benidipine hydrochloride in rats, dogs and monkeys. Xenobiot. Metab. Dispos. 5: 111-119
13. Mason, R. P., Champbell, S. F., Wang, S. D., Herbette, L. G. (1989) Comparison of location and binding for the positively charged 1,4-dihydropyridine calcium channel antagonist amlodipine with uncharged drugs of this class in cardiac membranes. Mol. Pharmacol. 36: 634-640
14. Micheli, D., Ratti, E., Toson, G., Gaviraghi, G. (1991) Pharmacology of lacidipine, a vascular-selective calcium antagonist. J. Cardiovasc. Pharmacol. 17 (Suppl. 4): S1-S8
15. Noda, H., Ito, Y., Fujita, T. (1990) The anti-hypertensive effect and benidipine hydrochloride in patients with essential hypertension. Jpn Pharmacol. Ther. 18 (Suppl. 4): S703-S711
16. 3H]benidipine hydrochloride into the lipid membrane. Clin. Rep. 25: 3887-3893
17. Rhodes, D. G., Sarmiento, J. G., Herbette, L. G. (1985) Kinetics of binding of membrane-active drugs to receptor sites. Diffusion-limited rates for a membrane bilayer approach of 1,4-dihydropyridine calcium channel antagonists to their active site. Mol. Pharmacol. 27: 612-623
18. Sheiner, L. B., Stanski, D. R., Vozeh, S., Miller, R. D., Ham, J. (1979) Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin. Pharmacol. Ther. 25: 358-371
19. Shimada, S., Nakajima, Y., Yamamoto, K., Sawada, Y., Iga, T. (1996) Comparative pharmacodynamics of eight calcium channel blocking agents in Japanese essential hypertensive patients. Biol. Pharm. Bull. 19: 430-437
20. Yamaoka, K., Tanigawara, Y., Nakagawa, T., Uno, T. (1981) A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacodyn. 4: 879-885
21. Young, H. S., Skita, V., Mason, R. P., Herbett, L. G. (1992) Molecular basis for the inhibition of 1,4-dihydropyridine calcium channel drugs binding to their receptors by a nonspecific site interaction mechanism. Biophys. J. 61: 1244-1255
22. Van Zwieten, P. A., Pfaffendorf, M. (1993) Pharmacology of the dihydropyridine calcium antagonists: relationship between lipophilicity and pharmacodynamic responses. J. Hypertens. 11 (Suppl. 6): S3-S8